EUR 58.35 at Lang & Schwarz: Rovi stock pre-market minus 0.26 percent versus the Xetra close
Published on 10/13/2026 at 07:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Rovi stock was EUR 58.35 pre-market at Lang & Schwarz.
- The price was 0.26 percent below the October 12 Xetra close of EUR 58.50.
- Rovi's next scheduled event is its nine-month 2026 results on November 5, 2026.
Rovi stock was EUR 58.35 at Lang & Schwarz at 7:46 a.m. CEST on October 13, 2026, down 0.26 percent versus the Xetra close of EUR 58.50 on October 12, 2026. The Spanish pharmaceutical company is scheduled to publish its first nine months 2026 financial results on November 5, 2026.
Pre-market price
Lang & Schwarz showed a bid of EUR 58.15 and an ask of EUR 58.55 at 7:46 a.m. CEST. The price was below the October 12 Xetra close by EUR 0.15. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Rovi stock.
What matters today
Rovi's next scheduled event is its nine-month 2026 financial results on November 5, 2026, according to the company's investor calendar. The next round-number level is EUR 60.00, which is 2.83 percent above the EUR 58.35 pre-market price. A May 13, 2026 listing from Jefferies showed a hold rating and a EUR 64.20 target, according to Bolsamania.
Market context: Market report IBEX 35.
